Discovery & Artifact Plan
Our senior Medysec expert reads device architecture, intended use, regulatory pathway, and existing cybersecurity evidence then delivers a written artifact plan and fixed-fee quote inside 5 business days.
FDA Postmarket Cybersecurity
Once a device is cleared, the security work changes shape. We help manufacturers monitor, patch, and report on connected devices already in the field, so security doesn't stop at clearance.

Attack Surface
FDA guidance and Section 524B set out what a postmarket programme must produce. This is the work we run for cleared devices.
Our Process
We establish monitoring, agree what counts as a critical finding, evaluate what arrives, support remediation, and keep the records your quality team has to file accurate and current.
Standards & Framework
Our postmarket work considers applicable FDA guidance, cybersecurity standards, vulnerability practices, and risk-management requirements relevant to the device and its market.
Step-by-Step Workflow
We analyze your device architecture, build complete cybersecurity evidence, and hand your team an audit-ready submission package.
Our senior Medysec expert reads device architecture, intended use, regulatory pathway, and existing cybersecurity evidence then delivers a written artifact plan and fixed-fee quote inside 5 business days.
Medysec runs hands-on threat modeling, SBOM authoring, security risk assessment, and penetration testing on the named device, using the agreed artifact plan as the work contract.
Two named Medysec experts review the package against FDA 2026 guidance check-by-check before handoff. Findings flagged, retested, and closed.
You get a one-hour walk-through with your regulatory lead, a Letter of Attestation, and a fixed-fee retest commitment if FDA raises cybersecurity deficiencies.
In Their Words
We work alongside device manufacturers to secure their connected medical devices and clear regulatory review. Here is what those teams have to say about us.


Qualysec Technologies Pvt Ltd's efforts resulted in improved security, risk mitigation, enhanced security controls, and compliance achievement. The team was responsive, flexible, and open to addressing the client's evolving needs. They maintained regular communication via email and virtual meetings.
Billy Sadhu Sharma Kumar
Head-V&V Engineering

Case Studies

A security assessment of a diagnostic desktop application used with the TearView platform, focused on protecting patient diagnostic data, strengthening application controls, and supporting the client’s FDA 510(k) documentation.
Read Case Study
A healthcare platform engagement that clarified security ownership, mapped critical attack paths, and improved evidence for release decisions.
Read Case Study
A practical cloud security review that helped a patient-facing product prioritise its most important configuration and access-control improvements.
Read Case StudyFDA Postmarket Cybersecurity FAQ
Tell us what you are working on and we will give you a straight read on scope, timeline, and cost.